These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38484324)

  • 1. Hormonal Contraception and Risk of Cardiometabolic Disease in Women with HIV.
    Norwood J; Jenkins CA; Bhatta M; Turner M; Bian A; Nelson J; Ransby I; Hughes D; Koethe JR; Sterling TR; Shepherd BE; Castilho JL
    J Womens Health (Larchmt); 2024 Jul; 33(7):966-974. PubMed ID: 38484324
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormonal Contraception and Risk of Psychiatric and Other Noncommunicable Diseases in HIV-Infected Women.
    Castilho JL; Jenkins CA; Shepherd BE; Bebawy SS; Turner M; Sterling TR; Melekhin VV
    J Womens Health (Larchmt); 2015 Jun; 24(6):481-8. PubMed ID: 25751720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
    Morrison CS; Chen PL; Kwok C; Baeten JM; Brown J; Crook AM; Van Damme L; Delany-Moretlwe S; Francis SC; Friedland BA; Hayes RJ; Heffron R; Kapiga S; Karim QA; Karpoff S; Kaul R; McClelland RS; McCormack S; McGrath N; Myer L; Rees H; van der Straten A; Watson-Jones D; van de Wijgert JH; Stalter R; Low N
    PLoS Med; 2015 Jan; 12(1):e1001778. PubMed ID: 25612136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial.
    Crook AM; Ford D; Gafos M; Hayes R; Kamali A; Kapiga S; Nunn A; Chisembele M; Ramjee G; Rees H; McCormack S
    Hum Reprod; 2014 Aug; 29(8):1810-7. PubMed ID: 24838704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Depot Medroxyprogesterone Acetate, Copper Intrauterine Devices, and Levonorgestrel Implants on Early HIV Disease Progression.
    Morrison CS; Hofmeyr GJ; Thomas KK; Rees H; Philip N; Palanee-Phillips T; Nanda K; Nair G; Onono M; Mastro TD; Lind M; Heffron R; Edward V; Deese J; Beksinska M; Beesham I; Stringer JSA; Baeten JM; Ahmed K;
    AIDS Res Hum Retroviruses; 2020 Aug; 36(8):632-640. PubMed ID: 32394723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    Noguchi LM; Richardson BA; Baeten JM; Hillier SL; Balkus JE; Chirenje ZM; Bunge K; Ramjee G; Nair G; Palanee-Phillips T; Selepe P; van der Straten A; Parikh UM; Gomez K; Piper JM; Watts DH; Marrazzo JM;
    Lancet HIV; 2015 Jul; 2(7):e279-87. PubMed ID: 26155597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of clinical and therapeutic factors on incident cardiovascular and cerebrovascular events in a population-based cohort of HIV-infected and non-HIV-infected adults.
    Tripathi A; Liese AD; Winniford MD; Jerrell JM; Albrecht H; Rizvi AA; Zhang J; Duffus WA
    Clin Cardiol; 2014 Sep; 37(9):517-22. PubMed ID: 25223811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of injectable hormonal contraception and women's risk of herpes simplex virus type 2 acquisition: a prospective study of couples in Rakai, Uganda.
    Grabowski MK; Gray RH; Makumbi F; Kagaayi J; Redd AD; Kigozi G; Reynolds SJ; Nalugoda F; Lutalo T; Wawer MJ; Serwadda D; Quinn TC; Tobian AAR
    Lancet Glob Health; 2015 Aug; 3(8):e478-e486. PubMed ID: 26094162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study.
    Lichtenstein KA; Armon C; Buchacz K; Chmiel JS; Buckner K; Tedaldi EM; Wood K; Holmberg SD; Brooks JT;
    Clin Infect Dis; 2010 Aug; 51(4):435-47. PubMed ID: 20597691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV incidence among women using intramuscular depot medroxyprogesterone acetate, a copper intrauterine device, or a levonorgestrel implant for contraception: a randomised, multicentre, open-label trial.
    Evidence for Contraceptive Options and HIV Outcomes (ECHO) Trial Consortium
    Lancet; 2019 Jul; 394(10195):303-313. PubMed ID: 31204114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormonal contraception and metabolic outcomes in women with or at risk for HIV infection.
    Womack JA; Scherzer R; Cole SR; Fennie K; Williams AB; Grey M; Minkoff H; Anastos K; Cohen MH; Tien PC
    J Acquir Immune Defic Syndr; 2009 Dec; 52(5):581-7. PubMed ID: 19950431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal contraceptive use and discontinuation among HIV-infected women in Uganda and Zimbabwe.
    Bengtson A; Kwok C; Salata RA; Byamugisha J; Chipato T; Rwambuya S; Moyo P; Morrison CS
    J Acquir Immune Defic Syndr; 2013 Aug; 63(4):506-13. PubMed ID: 23572011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hormonal contraception and the risk of HIV acquisition among women in South Africa.
    Morrison CS; Skoler-Karpoff S; Kwok C; Chen PL; van de Wijgert J; Gehret-Plagianos M; Patel S; Ahmed K; Ramjee G; Friedland B; Lahteenmaki P
    AIDS; 2012 Feb; 26(4):497-504. PubMed ID: 22156973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal contraception and HIV acquisition among women: an updated systematic review.
    Curtis KM; Hannaford PC; Rodriguez MI; Chipato T; Steyn PS; Kiarie JN
    BMJ Sex Reprod Health; 2020 Jan; 46(1):8-16. PubMed ID: 31919239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trends in contraceptive use according to HIV status among privately insured women in the United States.
    Haddad LB; Monsour M; Tepper NK; Whiteman MK; Kourtis AP; Jamieson DJ
    Am J Obstet Gynecol; 2017 Dec; 217(6):676.e1-676.e11. PubMed ID: 28866122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.
    Morrison CS; Chen PL; Nankya I; Rinaldi A; Van Der Pol B; Ma YR; Chipato T; Mugerwa R; Dunbar M; Arts E; Salata RA
    J Acquir Immune Defic Syndr; 2011 Jun; 57(2):157-64. PubMed ID: 21358412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
    Myer L; Denny L; Wright TC; Kuhn L
    Int J Epidemiol; 2007 Feb; 36(1):166-74. PubMed ID: 17175547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of endogenous progesterone levels in young women using hormonal contraception with recent HIV-1 infection.
    Boodhram R; Moodley D; Abbai N; Ramjee G
    BMC Womens Health; 2019 May; 19(1):63. PubMed ID: 31068152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.
    Whiteman MK; Jeng G; Samarina A; Akatova N; Martirosyan M; Kissin DM; Curtis KM; Marchbanks PA; Hillis SD; Mandel MG; Jamieson DJ
    Contraception; 2016 Jan; 93(1):17-24. PubMed ID: 26197261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV disease progression by hormonal contraceptive method: secondary analysis of a randomized trial.
    Stringer EM; Levy J; Sinkala M; Chi BH; Matongo I; Chintu N; Stringer JS
    AIDS; 2009 Jul; 23(11):1377-82. PubMed ID: 19448528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.